Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 274

1.

Severity of portal hypertension and prediction of postoperative liver failure after liver resection in patients with Child-Pugh grade A cirrhosis.

Chen X, Zhai J, Cai X, Zhang Y, Wei L, Shi L, Wu D, Shen F, Lau WY, Wu M.

Br J Surg. 2012 Dec;99(12):1701-10. doi: 10.1002/bjs.8951.

PMID:
23132418
2.

Morphologic severity of cirrhosis determines the extent of liver resection in patients with hepatocellular carcinoma and Child-Pugh grade A cirrhosis.

Zhou SJ, Zhang EL, Liang BY, Zhang ZY, Dong KS, Hou P, Chen XP, Xiong M, Huang ZY.

J Surg Res. 2016 Feb;200(2):444-51. doi: 10.1016/j.jss.2015.08.027. Epub 2015 Aug 28.

PMID:
26470819
3.

The critical value of remnant liver volume-to-body weight ratio to estimate posthepatectomy liver failure in cirrhotic patients.

Lin XJ, Yang J, Chen XB, Zhang M, Xu MQ.

J Surg Res. 2014 May 15;188(2):489-95. doi: 10.1016/j.jss.2014.01.023. Epub 2014 Jan 24.

PMID:
24569034
4.

Prediction of posthepatectomy liver failure based on liver stiffness measurement in patients with hepatocellular carcinoma.

Nishio T, Taura K, Koyama Y, Tanabe K, Yamamoto G, Okuda Y, Ikeno Y, Seo S, Yasuchika K, Hatano E, Okajima H, Kaido T, Tanaka S, Uemoto S.

Surgery. 2016 Feb;159(2):399-408. doi: 10.1016/j.surg.2015.06.024. Epub 2015 Jul 21.

PMID:
26209567
5.

Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis.

Boleslawski E, Petrovai G, Truant S, Dharancy S, Duhamel A, Salleron J, Deltenre P, Lebuffe G, Mathurin P, Pruvot FR.

Br J Surg. 2012 Jun;99(6):855-63. doi: 10.1002/bjs.8753. Epub 2012 Apr 17.

PMID:
22508371
6.

Intraoperative portal venous pressure and long-term outcome after curative resection for hepatocellular carcinoma.

Hidaka M, Takatsuki M, Soyama A, Tanaka T, Muraoka I, Hara T, Kuroki T, Kanematsu T, Eguchi S.

Br J Surg. 2012 Sep;99(9):1284-9. doi: 10.1002/bjs.8861.

PMID:
22864890
7.

[Evaluation of liver reserve function by ICGR15 detection before hepatectomy for hepatocellular carcinoma].

Lao XM, Zhang YQ, Guan YX, Guo RP, Lin XJ, Yuan YF, Li JQ, Li GH.

Ai Zheng. 2004 Oct;23(10):1213-7. Chinese.

PMID:
15473939
8.

von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.

Ferlitsch M, Reiberger T, Hoke M, Salzl P, Schwengerer B, Ulbrich G, Payer BA, Trauner M, Peck-Radosavljevic M, Ferlitsch A.

Hepatology. 2012 Oct;56(4):1439-47. doi: 10.1002/hep.25806. Epub 2012 Aug 27.

PMID:
22532296
9.

Splenic arterial ligation prevents liver injury after a major hepatectomy by a reduction of surplus portal hypertension in hepatocellular carcinoma patients with cirrhosis.

Sato Y, Kobayashi T, Nakatsuka H, Yamamoto S, Oya H, Watanabe T, Hatakeyama K.

Hepatogastroenterology. 2001 May-Jun;48(39):831-5.

PMID:
11462934
10.
11.

Evaluation of liver function for the application of preoperative portal vein embolization on major hepatic resection.

Wakabayashi H, Yachida S, Maeba T, Maeta H.

Hepatogastroenterology. 2002 Jul-Aug;49(46):1048-52.

PMID:
12143199
12.

Is portal hypertension a contraindication to hepatic resection?

Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, Ramacciato G, Grazi GL, Pinna AD.

Ann Surg. 2009 Dec;250(6):922-8. doi: 10.1097/SLA.0b013e3181b977a5.

PMID:
19855258
13.

Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.

Giannini EG, Savarino V, Farinati F, Ciccarese F, Rapaccini G, Marco MD, Benvegnù L, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group.

Liver Int. 2013 Nov;33(10):1594-600. doi: 10.1111/liv.12199. Epub 2013 May 8.

PMID:
23654354
14.

Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.

Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J; Portal Hypertension Collaborative Group.

Gastroenterology. 2007 Aug;133(2):481-8. Epub 2007 May 21.

PMID:
17681169
15.

Usefulness of Mac-2 Binding Protein Glycosylation Isomer for Prediction of Posthepatectomy Liver Failure in Patients With Hepatocellular Carcinoma.

Okuda Y, Taura K, Yoshino K, Ikeno Y, Nishio T, Yamamoto G, Tanabe K, Koyama Y, Hatano E, Tanaka S, Uemoto S.

Ann Surg. 2017 Jun;265(6):1201-1208. doi: 10.1097/SLA.0000000000001836.

PMID:
27355265
16.

Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.

Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, Imamura H, Sugawara Y, Kokudo N, Makuuchi M.

Gastroenterology. 2008 Jun;134(7):1908-16. doi: 10.1053/j.gastro.2008.02.091. Epub 2008 Mar 8.

PMID:
18549877
17.

Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma.

Wang YY, Zhong JH, Su ZY, Huang JF, Lu SD, Xiang BD, Ma L, Qi LN, Ou BN, Li LQ.

Br J Surg. 2016 May;103(6):725-734. doi: 10.1002/bjs.10095. Epub 2016 Mar 23.

PMID:
27005482
18.

Posthepatectomy portal vein pressure predicts liver failure and mortality after major liver resection on noncirrhotic liver.

Allard MA, Adam R, Bucur PO, Termos S, Cunha AS, Bismuth H, Castaing D, Vibert E.

Ann Surg. 2013 Nov;258(5):822-9; discussion 829-30. doi: 10.1097/SLA.0b013e3182a64b38.

PMID:
24045452
19.

The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data.

Hong WK, Kim MY, Baik SK, Shin SY, Kim JM, Kang YS, Lim YL, Kim YJ, Cho YZ, Hwang HW, Lee JH, Chae MH, Kim HA, Kang HW, Kwon SO.

Clin Mol Hepatol. 2013 Dec;19(4):370-5. doi: 10.3350/cmh.2013.19.4.370. Epub 2013 Dec 28.

20.

Correlations of portal hypertensive gastropathy of hepatitis B cirrhosis with other factors.

Pan WD, Xun RY, Chen YM.

Hepatobiliary Pancreat Dis Int. 2002 Nov;1(4):527-31.

Supplemental Content

Support Center